Correction to: Scientific Reports 10.1038/s41598-019-52165-x, published online 31 October 2019
The Article contains a typographical error in Table 2 for the concentration range of the patient group for DMS.
The correct Table 2 appears below as Table 1.
Table 1.
Exhaled amounts of selected alveolar VOCs in the study population.
| Ethanol [ppbV] | Acetone [ppbV] | Isopropanol [ppbV] | DMS [ppbV] | Isoprene [ppbV] | Pentanal [ppbV] | Limonen [ppbV] | ||
|---|---|---|---|---|---|---|---|---|
| Controls | 82.4a,b,c (20.7–554) | 232* (186–306) | 784a,b (287–28,963) | 10.0a,b,c (0.99–151) | 49.6a,b,c (7.44–153) | 5.30a,b,c (1.36–36.9) | 51.8 (4.81–1,192) | |
| Patients | 171a (44.7–1856) | 238* (204–256) | 1223a (481–15011) | 19.6a (4.28–89.6) | 112a (8.36–291) | 13.5a (6.11–101) | 66.7 (13.9–513) | |
| HbA1c< 8% | 150b (71.6–1203) | 238 (211–256) | 924c (481–2509) | 20.0b (4.53–89.6) | 105b (49.0–291) | 10.6b,d (6.11–30.9) | 66.7 (14.8–513) | |
| HbA1c> 8% | 221c (44.7–1856) | 240 (204–255) | 1607b,c (686–15011) | 17.1c (4.28–44.1) | 118c (8.36–265) | 16.2c,d (8.27–101) | 66.8 (13.9–209) | |
Data is given as median and range. Superscripts denote significantly different concentrations of the respective analytes between identically labelled groups. DMS, dimethylsulfide.
acontrols vs patients: p < 0.001 for ethanol, DMS, isoprene, and pentanal, p = 0.002 for isopropanol; bcontrols vs patients with good metabolic control (HbA1c < 8%): p < 0.001 for ethanol, DMS, isoprene, and pentanal; ccontrols vs patients with poor metabolic control (HbA1c > 8%): p < 0.001 for ethanol, isopropanol, isoprene, and pentanal, p = 0.03 for DMS; dpatiens with poor vs those with good metabolic control: p < 0.001 for isopropanol and p = 0.012 for pentanal.
Additionally, the Article contains an error in Figure 2 whereby the data from three diabetic patients was accidently omitted.
The correct Figure 2 appears below as Figure 1.
Figure 1.
.